Mechanisms of Formation and Function of Eosinophil Lipid Bodies: Inducible Intracellular Sites Involved in Arachidonic Acid Metabolism

Memorias do Instituto Oswaldo Cruz

Volumn 92 SUPPL. 2, Issue , 1997, Pages 135-140

  Bozza, Patricia T ^b   Yu, Wengui ^a   Weller, Peter F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Eicosanoids; Eosinophils; Inflammation; Lipid bodies

Indexed keywords

ARACHIDONIC ACID; AUTACOID; ICOSANOID; MEMBRANE LIPID;

BIOSYNTHESIS; DRUG ANTAGONISM; EOSINOPHIL; HUMAN; HYPEREOSINOPHILIC SYNDROME; IMMUNOLOGY; INFLAMMATION; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ARACHIDONIC ACID; EICOSANOIDS; EOSINOPHILS; HUMANS; HYPEREOSINOPHILIC SYNDROME; INFLAMMATION; INFLAMMATION MEDIATORS; MEMBRANE LIPIDS; SIGNAL TRANSDUCTION;

EID: 0031317725     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761997000800018     Document Type: Article

References (55)

1. 2 activation in human neutrophils. Differential actions of diacylglycerols and alkylacylglycerols in priming cells for stimulation by N-formyl-met-leuphe. J Biol Chem 263: 16787-16795.
2. 2, 5-lipoxygenase and acetyltransferase activation in human neutrophils. Bioch Biophys Acta 1991: 178-184.
3. Beil WJ, Weller PF, Peppercorn MA, Galli SJ, Dvorak AM 1995. Ultrastructural immunogold localization of subcellular sites of TNF-α in colonic Crohn's disease. J Leuk Biol 58: 284-298.
4. Bozza PT, Payne JL, Goulet JL, Weller PF 1996a. Mechanisms of PAF-induced lipid body formation: a requisite role for 5-lipoxygenase in the compartmentalization of neutrophil lipids. J Exp Med 183: 1515-1525.
5. Bozza PT, Payne JL, Morham SG, Langenbach R, Smithies O, Weller PF 1996b. Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin. Proc Natl Acad Sci USA 93: 11091-11096.
6. Bozza PT, Yu W, Penrose JF, Morgan ES, Dvorak AM, Weller PF 1997. Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation. J Exp Med 186: 909-920.
7. Braquet P, Touqui L, Shen T, Vargaftig BB 1987. Perspectives in platelet-activating factor research. Pharmacol Rev 39: 2-97.
8. Brock TG, Paine R Jr, Peters-Golden M 1994. Localization of 5-lipoxygenase to the nucleus of unstimulated rat basophilic leukemia cells. J Biol Chem 269: 22059-22066.
9. Cerletti C 1985. Interaction of non-steroidal anti-inflammatory drugs on platelet cyclo-oxygenase and lipoxygenase activity. Int J Tissue React 7: 309-312.
10. Cerletti C, Livio M, Doni MG, De Gaetano G 1983. Salicylate fails to prevent the inhibitory effect of 5,8,11,14- eicosatetraynoic acid on human platelet cyclo-oxygenase and lipoxygenase activities. Biochim Biophys Acta 759: 125-127.
11. 2 from the human monocytic cell line U937. Proc Natl Acad Sci USA 87: 7708-7712.
12. Coimbra A, Lopes-Vaz A 1971. The presence of lipid droplets and the absence of stable sudanophilia in osmium-fixed human leukocytes. J Histochem Cytochem 19: 551-557.
13. Dvorak AM, Morgan E, Schleimer RP, Ryeom SW, Lichtenstein LM, Weller PF 1992. Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to nonmembrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type-II pneumocytes and neutrophils. J Histochem Cytochem 40: 759-769.
14. Dvorak AM, Morgan E, Tzizik DM, Weller PF 1994. Prostaglandin endoperoxide synthase (cyclooxygenase): ultrastructural localization to nonmembrane-bound cytoplasmic lipid bodies in human eosinophils and murine 3T3 fibroblasts. Int Arch Allergy Immunol 105: 245-250.
15. Henderson WRJr 1994. The role of leukotrienes in inflammation. Ann Intern Med 121: 684-697.
16. Kujubu DA, Herschman HR 1992. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J Biol Chem 267: 7991-7994.
17. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D, Hwang D 1992. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 267: 25934-25938.
18. 2 that exhibits lysophospholipase activity. J Biol Chem 266: 11366-11371.
19. 2 is coupled to hormonally regulated release of arachidonic acid. Proc Nail Acad Sci USA 89: 6147-6151.
20. 2 is phosphorylated and acivated by MAP kinase. Cell 72: 269-278.
21. MacGlashan DJr, Peters SP, Warner J, Lichtenstein LM 1986. Characteristics of human basophil sulphidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimer cross-links. J Immunol 136: 2231-2236.
22. MacGlashan DJr, Schleimer RP, Peters SP, Schulman ES, Adams GKIII, Newball NH, Lichtenstein LM 1982. Generation of leukotrienes by purified human lung mast cells. J Clin Invest 70: 747-751.
23. Murphy PM 1994. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 12: 593-633.
24. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB 1986. Arachidonic acid metabolism. Ann Rev Biochem 55: 69-102.
25. Paajanen H, Mannisto J, Uotila P 1982. Aspirin inhibits arachidonic acid metabolism via lipoxygenase and cyclo-oxygenase in hamster isolated lungs. Prostaglandins 23: 731-741.
26. 2 to the nuclear fraction upon macrophage activation. Biochem Biophys Res Commun 196: 147-153.
27. Punnonen K, Uotila P 1984. The effect of aspirin on the metabolism of exogenous arachidonic acid in human polymorphonuclear leukocytes. Prostaglandins Leukot Med 15: 177-185.
28. Reddy ST, Herschman HR 1994. Ligand-induced prostaglandin synthesis requires expression of the TIS10/ PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J Biol Chem 269: 15473-15480.
29. Reginato AJ, Schumacher HR, Allan DA, Rabinowitz JL 1985. Acute monoarthritis associated with lipid liquid crystals. Ann Rheum Dis 44: 537-543.
30. Reid GK, Kargman S, Vickers PJ, Mancini JA, Leveille C, Ethier D, Miller DK, Gillard JW, Dixon RA, Evans JF 1990. Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. Biol Chem 265: 19818-19823.
31. Robinson JM, Karnovsky ML, Karnovsky MJ 1982. Glycogen accumulation in polymorphonuclear leukocytes, and other intracellular alterations that occur during inflammation. J Cell Biol 95: 933-942.
32. Rouzer CA, Kargman S 1988. Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J Biol Chem 263: 10980-10988.
33. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237: 1171-1176.
34. Schlesinger PA, Stillman MT, Peterson L 1982. Polyarthritis with birefringent lipid within synovial fluid macrophages: case report and ultrastructural study. Arthritis Rheum 25: 1365-1368.
35. Serhan CN 1994. Eicosanoids in leukocyte function. Cur Op Hematol 1: 69-77.
36. Serhan CN 1996. Signalling the fat controller. Nature 384: 23-24.
37. Shutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M 1992. TNF activates NF-kB by phosphatidylcholine-specific phospholipase-C-induced "acidic" sphingomyelin breakdown. Cell 71: 765-776.
38. Siegel MI, McConnell RT, Porter NA, Selph JL, Truax JF, Vinegar R, Cuatrecasas P 1980. Aspirin-like drugs inhibit arachidonic acid metabolism via lipoxygenase and cyclo-oxygenase in rat neutrophils from carrageenan pleural exudates. Biochem Biophys Res Commun 92: 688-695.
39. Sigal E 1991. The molecular biology of mammalian arachidonic acid metabolism. Am J Physiol 260: L13-L28.
40. Smith WL, DeWitt DL, Kraemer SA, Andrews MJ, Hla T, Maciag T, Shimokawa, T 1990. Structure-function relationships in sheep, mouse, and human prostaglandin endoperoxide G/H synthases. In B Samuelsson et al.(eds.). Advances in Prostaglandin, Thromboxane and Leukotriene Research. Raven Press, New York.
41. Smith W L, Garavito RM, DeWitt DL 1996. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271: 33157-33160.
42. Smith WL, Meade EA, DeWitt DL 1994. Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and-2. Ann N Y Acad Sci 714: 136-142.
43. Solley GO, Maldonado JE, Gleich GJ, Giulani ER, Hoagland HC, Pierre RV, Brown ALJr 1976. Endomyocardiophaty with eosinophilia. Mayo Clin Proc 51: 697-708.
44. Stewart AG, Dubbin PN, Harris T, Dusting GJ 1990. Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells. Proc Natl Acad Sci USA 87: 3215-3219.
45. Triggiani M, Oriente A, Seeds MC, Bass DA, Marone G, Chilton FH 1995. Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. J Exp Med 182: 1181-1190.
46. Villanueva M, Heckenberger R, Strobach H, Palmer M, Schror K 1993. Equipotent inhibition by R (-)-, S (+)- and racemic ibuprofen of human polymorphonuclear cell function in vitro. Br J Clin Pharmac 35: 235-242.
47. Weinstein J 1980. Synovial fluid leukocytosis associated with intracellular lipid inclusions. Arch Intern Med 140: 560-561.
48. Weller PF, Ackerman SJ, Nicholson-Weller A, Dvorak AM 1989. Cytoplasmic lipid bodies of human neutrophilic leukocytes. Am J Pathol 135: 947-959.
49. 4. Proc Natl Acad Sci USA 80: 7626-7630.
50. Weller PF, Monahan-Earley RA, Dvorak HF, Dvorak AM 1991a. Cytoplasmic lipid bodies of human eosinophils: subcellular isolation and analysis of arachidonate incorporation. Am J Pathol 138: 141-148.
51. Weller PF, Ryeom SW, Picard ST, Ackerman SJ, Dvorak AM 1991b. Cytoplasmic lipid bodies of neutrophils: Formation induced by cis-unsaturated fatty acids and mediated by protein kinase C. J Cell Biol 113: 137-146.
52. Woods JW, Coffey MJ, Brock TG, Singer II, Peters-Golden M 1995. 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J Clin Invest 95: 2035-2046.
53. Woods JW, Evans JF, Ethier D, Scott S, Vickers P J, Hearn L, Heibein JA, Charleson S, Singer II 1993. 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J Exp Med 178: 1935-1946.
54. 2 at cytoplasmic lipid bodies. Am J Pathol (in press).
55. 2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells. J Biol Chem 267: 13830-13835.